After graduating from Bishop Kearney, Maureen attended the City University of New York Honors College- College of Staten Island on a full academic scholarship. Maureen graduated with a B.S. in Bioinformatics with a concentration in Computer Science in December 2004. During her time at Bishop Kearney, Maureen participated in the Westinghouse Research Program where her research on Amyotrophic Lateral Sclerosis (ALS) and the Human Genome Project prepared her for the Biology and Bioinformatics program in college.
During her undergraduate tenure, Maureen interned with the NYC Office of the Chief Medical Examiner on the World Trade Center DNA Identification Team (2002) and the NYPD Crime Scene Unit (2003). In 2003, she was the recipient of a Merck Undergraduate Research Stipend which allowed her to conduct bench research in the Cell and Microbiology research labs at the College of Staten Island. Her research on the effects of phthalates on peroxisome proliferation and their link to liver cancer led to multiple publications and presentations at the Microscopy and Microanalysis Conference in 2005 and local microscopy conferences around NYC.
In early 2005, Maureen relocated to Pittsburgh, PA to pursue a career in Molecular Pathology research at the University of Pittsburgh. At the University of Pittsburgh, Maureen researched genomic changes in prostate cancer. She began a career in the molecular diagnostics industry focusing on oncology in early 2006. Maureen has spent almost 12 years working in this industry focusing on all types of cancer. Her career has evolved from bench research to sales and marketing to business development with some of the country’s leading molecular diagnostics and information companies.
Presently, Maureen leads clinical collaborations and the Precision Medicine Consortium at Foundation Medicine, a leading molecular information company that collaborates with physicians, patients and bio-pharma partners to uncover insights that transform cancer care. Maureen collaborates with many of the leading cancer centers around the country to further advance genomic testing and molecular information options for patients with advanced-stage cancer. Although her career takes her around the country almost weekly, Maureen continues to reside in Pittsburgh, PA with her husband, Art and their daughter, Elizabeth.